PTC THERAPEUTICS, INC. (PTCT)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 400M 800M 1.2B Q3 '24: 196.8M Q4 '24: 213.2M Q1 '25: 1.2B Q2 '25: 178.9M Q3 '25: 211M Q4 '25: 164.7M Q1 '26: 272.6M Q2 '26: 360.5M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Gross Profit Quarterly

0 35M 70M 105M Q1 '18: 53M Q2 '18: 66.2M Q3 '18: 50.3M Q4 '18: 82.1M Q1 '19: 51.2M Q2 '19: 82.3M Q3 '19: 68.4M Q4 '19: 92.9M Q1 '18 Q2 '18 Q3 '18 Q4 '18 Q1 '19 Q2 '19 Q3 '19 Q4 '19

Revenue minus cost of sales. This filer tags no gross profit of its own..

Operating Income Quarterly

-350M 0 350M 700M 1.1B Q3 '24: -54.5M Q4 '24: -162.4M Q1 '25: 970.2M Q2 '25: -35M Q3 '25: 3M Q4 '25: -71.3M Q1 '26: 45M Q2 '26: 149M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Net Income Quarterly

-300M 0 300M 600M 900M Q3 '24: -106.7M Q4 '24: -65.9M Q1 '25: 866.6M Q2 '25: -64.8M Q3 '25: 15.9M Q4 '25: -135M Q1 '26: -2.8M Q2 '26: 83.5M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Cost of Revenue Quarterly

0 1.5M 3M 4.5M Q1 '18: 3M Q2 '18: 2.6M Q3 '18: 3.3M Q4 '18: 3.8M Q1 '19: 2.4M Q2 '19: 3.2M Q3 '19: 3M Q4 '19: 3.5M Q1 '18 Q2 '18 Q3 '18 Q4 '18 Q1 '19 Q2 '19 Q3 '19 Q4 '19

Operating Cash Flow Quarterly

-300M 0 300M 600M 900M Q3 '24: -77M Q4 '24: -30M Q1 '25: 870.1M Q2 '25: -58.3M Q3 '25: -66.3M Q4 '25: -34.3M Q1 '26: -59M Q2 '26: 129.1M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Free Cash Flow Quarterly

-300M 0 300M 600M 900M Q3 '24: -77.5M Q4 '24: -33.8M Q1 '25: 868.4M Q2 '25: -59.6M Q3 '25: -69.8M Q4 '25: -36.6M Q1 '26: -60.2M Q2 '26: 126.9M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 35M 70M 105M Q1 '24: 76.5M Q2 '24: 76.7M Q3 '24: 76.9M Q1 '25: 86.4M Q2 '25: 78.2M Q3 '25: 87.1M Q1 '26: 82.5M Q2 '26: 92M Q1 '24 Q2 '24 Q3 '24 Q1 '25 Q2 '25 Q3 '25 Q1 '26 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-6.00 -3.00 0.00 3.00 6.00 9.00 Q3 '24: -5.94 Q4 '24: -4.73 Q1 '25: 6.51 Q2 '25: 6.97 Q3 '25: 8.56 Q4 '25: 7.78 Q1 '26: -2.29 Q2 '26: -0.54 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.